Fig. 2
From: Diagnostic value of plasma-derived exosomal miR-223 for epithelial ovarian cancer
Plasma exosome-derived miR-223 levels at different EOC stages. A Plasma CA125 expression levels in plasma were compared among EOC patients, patients with benign disease and healthy subjects. B Plasma exosomal miR-223 levels compared among healthy subjects, patients with benign disease and EOC patients at different FIGO stage. C Exosomal miR-223 expression levels in plasma were significantly upregulated in metastatic EOC patients when compared with non-metastatic EOC patients. (**P < 0.01, ***P < 0.001, ****P < 0.0001, ns, not significant)